Bioseeker

BioSeeker Group is an independent, privately owned company based in Sweden since 1999. They focus on business, competitive intelligence in oncology and operate in two business areas: consulting and publishing. BioSeekers Group's mission is to excel our customer's business operations by objective and unbiased research and analysis.

Results 1 - 20 of 74

previous 1 2 3 4 next

last

Title	Date	Price
Protein Kinase Therapeutics in Oncology Where to Commercialize?	Oct 2009	£2,215
Competitive Outlook on Lung Cancer Drug Development The Missing Handbook to New Product Planning and Portfolio Planning	Aug 2009	£2,240
Lymphoma Drug Development Strategies at Work Define Your Competition	Jun 2009	£1,780
Therapeutic Peptides in Oncology Favorable Conditions But Where to Commercialize?	May 2009	£3,235
Leukemia A Competitive Analysis to New Products, Portfolio Planning, Licensing & Acquisition Through Pipeline Benchmarking	Apr 2009	£1,780
Complete Target Atlas in Oncology Drug Development: From Tumor to Targeted Therapy	Mar 2009	£2,835
Triple Target Atlas in Oncology Drug Development	Mar 2009	£2,835
Target Atlas in Oncology Drug Development: Targeted Therapies	Mar 2009	£3,750
Target Atlas in Oncology Drug Development: Major Tumor Types	Mar 2009	£2,835
Analytical Tool - Breast Cancer	Jan 2009	£2,835
Analytical Tool - Vaccines	Jan 2009	£2,835
Melanoma Drug Pipeline Update 2009	Jan 2009	£1,370
Immunotherapy in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,825
Renal Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Analytical Tool - Melanoma	Jan 2009	£2,835
Prostate Cancer: Drug Pipeline Update 2009	Jan 2009	£1,370
Analytical Tool - Apoptosis in Oncology	Jan 2009	£2,835
Analytical Tool - Prostate Cancer A Therapeutic & Competitive Insight	Jan 2009	£2,835
Pancreatic Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Analytical Tool - Colorectal Cancer	Jan 2009	£2,835